| Controversial GLP-1 Event Reports Signal Warning Fri, 19 Apr, 2013 03:23 PM PDT Today an independent body released the results of its research indicating that an entire class of type-2 diabetes drugs known as incretin mimetics may carry up to 25 times the risk of developing pancreatic cancer for patients taking these drugs. These drugs are known commercially as Januvia, Byetta, Vi... Continue reading | | |
No comments:
Post a Comment